Skip to main content
Population Health Learning Network
Annals of Long-Term Care
First Report Managed Care
Integrated Healthcare Executive
Pharmacy Learning Network
Veterans Health Today
Chronic Liver Disease
Acute Myeloid Leukemia
Psych & Mental Health
Submit a Manuscript
Correlation Between PD Nonmoter Symptoms and Medication Nonadherence
True or False: Nonmoter symptoms are associated with medication nonadherence in patients with Parkinson disease.
Parkinson Disease Coping Types
According to a recent study, strategies to manage life with Parkinson disease can be categorized into how many predominate coping types?
Growing Economic Burden of Parkinson Disease
True or False: The total economic burden across an estimated 1.04 million US residents diagnosed with Parkinson disease is $79 billion.
Benefits of Early Treatment Initiation in PD
True or False: Earlier treatment initiation improves outcomes for patients with PD.
Does Stigma Impact Use of Walking Aids?
True or False: Walking aids have the potential to increase functional mobility in patients with Parkinson disease, but they often are not accepted by patients because they signal dependency.
Factors Determining Health Care Costs Among PD Patients
Based on recent data, what determining factor plays a significant role in the substantially varied Parkinson-related health care costs among the Medicare population?
Weighing Treatment Options for Patients With Tremor-Dominant Parkinson Disease
Researchers recently conducted a cost-effectiveness analysis and compared the use of deep brain stimulation with magnetic resonance-guided focused ultrasound for patients with tremor-dominant Parkinson disease.
Understanding the Benefits of Early Treatment Initiation for PD
True or False: Earlier initiation of treatment for patients with Parkinson disease does not lead to worse outcomes compared to later treatment initiation and may offer a small improvement.
Is Telerehab Economically Beneficial for Speech Therapy in PD?
True or False: From a patient perspective, telerehabilitation treatment cost slightly more than in-person treatment for speech therapy among patients with Parkinson disease.
How Treatment Costs for Neurologic Drugs Impact Adherence Rates
When out-of-pocket costs were increased by this amount, patients with dementia and neuropathy on gabapentinoids experienced significantly lower medication adherence.
Stay in the know.
Population Health Learning Network Newsletter
Back to Top